The standard case for the fund is to invest in rounds with 6 partakers. Despite the UBS Oncology Impact Fund, startups are often financed by SunStates Fund, Samsara BioCapital, Redmile Group. The meaningful sponsors for the fund in investment in the same round are Samsara BioCapital, Redmile Group, EcoR1 Capital. In the next rounds fund is usually obtained by Samsara BioCapital, Redmile Group, EcoR1 Capital.
The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019. The common things for fund are deals in the range of more than 100 millions dollars.
Among the various public portfolio startups of the fund, we may underline ElevateBio, ElevateBio, Oncorus Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Medical. The fund has exact preference in a number of founders of portfolio startups.
Related Funds
| Fund Name | Location |
| AAC Capital Partners | Amsterdam, Noord-Holland, The Netherlands |
| Centre For Research And Innovation In The Bio-Economy | Canada, Ontario, Thunder Bay |
| dmg :: information | England, London, United Kingdom |
| European Venture Investment Group | - |
| GameStop Digital Ventures | Grapevine, Texas, United States |
| Gen3 Partners | Boston, Massachusetts, United States |
| Global Chance Fund | Bayern, Germany, Landshut |
| Heidelpay | Baden-Wurttemberg, Germany, Heidelberg |
| Hengbao | Beijing, Beijing, China |
| Hersh Interactive Group | - |
| Life Card Co. | Chiba, Japan, Minato |
| Lobb Heng Group China | China, Shanghai |
| Mengxiangzhe Dianying | Beijing, Beijing, China |
| Mingyin Guoji Ziben Touzi | Beijing, Beijing, China |
| Ofek Venture Fund | Israel, Tel Aviv, Tel Aviv District |
| Peach Ventures | England, London, United Kingdom |
| PPG Industries | Pennsylvania, Pittsburgh, United States |
| Zen Water Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Repare Therapeutics | $82M | 04 Sep 2019 | Montreal, Quebec, Canada | ||
Oncorus | $79M | 21 Aug 2019 | Cambridge, Massachusetts, United States | ||
ElevateBio | $150M | 13 May 2019 | Cambridge, Massachusetts, United States | ||
Cullinan Oncology | $150M | 03 Oct 2017 | Cambridge, Massachusetts, United States | ||
Repare Therapeutics | $68M | 22 Jun 2017 | Montreal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Repare Therapeutics | $82M | 04 Sep 2019 | Montreal, Quebec, Canada | ||
Oncorus | $79M | 21 Aug 2019 | Cambridge, Massachusetts, United States | ||
ElevateBio | $150M | 13 May 2019 | Cambridge, Massachusetts, United States | ||
Cullinan Oncology | $150M | 03 Oct 2017 | Cambridge, Massachusetts, United States | ||
Repare Therapeutics | $68M | 22 Jun 2017 | Montreal, Quebec, Canada |
